Value of the 340B drug discount program

Hagop Kantarjian; Robert Chapman

doi:10.1001/jamaoncol.2015.2168

Value of the 340B drug discount program

Hagop Kantarjian, Robert Chapman

Leukemia

Research output: Contribution to journal › Short survey › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	1029-1030
Number of pages	2
Journal	JAMA Oncology
Volume	1
Issue number	8
DOIs	https://doi.org/10.1001/jamaoncol.2015.2168
State	Published - Nov 2015

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2015.2168

Cite this

@article{107b5f77668f4092a2f71de6c4812da7,

title = "Value of the 340B drug discount program",

author = "Hagop Kantarjian and Robert Chapman",

year = "2015",

month = nov,

doi = "10.1001/jamaoncol.2015.2168",

language = "English (US)",

volume = "1",

pages = "1029--1030",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Value of the 340B drug discount program

AU - Kantarjian, Hagop

AU - Chapman, Robert

PY - 2015/11

Y1 - 2015/11

UR - http://www.scopus.com/inward/record.url?scp=85010664401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010664401&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2015.2168

DO - 10.1001/jamaoncol.2015.2168

M3 - Short survey

C2 - 26313652

AN - SCOPUS:85010664401

SN - 2374-2437

VL - 1

SP - 1029

EP - 1030

JO - JAMA Oncology

JF - JAMA Oncology

IS - 8

ER -

Value of the 340B drug discount program

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this